Yet, a case-control screening study of ABRAXAS1 missense and non-coding mutations in non-isolated populations of the Breast Cancer Family Registry did not reveal significant association with breast cancer risk [30]. The gene discussed is ABRAXAS1; the disease is breast cancer.